New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

U.S. CDC says COVID vaccine-related myocarditis much lower for children than teens

The U.S. Centers for Diseases Control and Prevention (CDC) on May 19 said reports of heart inflammation linked to the Pfizer/BioNTech COVID-19 vaccine have been much lower in 5- to 11-year-old boys than in adolescents and young men, representing only a slightly elevated rate than normal.

3

Life sciences companies shore up resources as US confirms first monkeypox case

A man in Massachusetts became the first person reported to have a case of monkeypox in the United States since 2021. The man contracted monkeypox after traveling to Canada, although Quebec’s Ministry of Health and Social Services told CBC News that no cases had been reported to the agency. SIGA Technologies is prepared to provide treatment to those infected with monkeypox.

4

Where we are: Omicron BA.2 persists while vaccines lower risk of long COVID

There appears to be a rise in COVID-19 illnesses, driven by Omicron subvariants, which may be better able to evade immunity from vaccines and previous infections and lower public health measures by the public such as masking and social distancing.

7

U.S. advisory panel to weigh in on COVID boosters for children

An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) is meeting on May 19 to discuss whether to recommend COVID-19 vaccine booster shots for children ages 5 to 11, a group that is just 29% vaccinated so far.

8

Havas Health & You Appoints Dan Rubin as President of Havas Health +

To continue to support health and wellness companies’ rapidly expanding cultural relevance and dominance of global content, Havas Health & You (HH&Y) announced that industry veteran Dan Rubin will join the network. He will work closely with global executive leadership and existing President and CCO Allison Ceraso to shape the future vision for Havas Health +, a fully integrated experience agency on the rise. Havas Health + has generated double-digit growth for the past 3 years, growing both HCP and DTC practices through new client wins and brand launches.

10

EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate

Valneva SE confirmed that the European Medicines Agency accepted the filing of a marketing authorization application (MAA) for the specialty vaccine company’s inactivated, whole-virus COVID-19 vaccine candidate, VLA2001.